These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1344459)

  • 61. [Thrombocytic-vascular hemostasis and the rheological properties of the blood during the tenolol treatment of hypertension patients].
    Zadionchenko VS; Bagatyrova KM; Stankevich TV
    Kardiologiia; 1993; 33(3):40-2. PubMed ID: 8104255
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of n-tyrosol on blood viscosity and platelet aggregation.
    Plotnikov MB; Chernysheva GA; Smol'yakova VI; Maslov MY; Cherkashina IV; Krysin AP; Sorokina IV; Tolstikova TG
    Bull Exp Biol Med; 2007 Jan; 143(1):61-3. PubMed ID: 18019014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinico-hemorheological aspects of the course of hypertension].
    Shchepotin BM; Ena IaM; Zaritskaia VN
    Kardiologiia; 1989 Sep; 29(9):18-21. PubMed ID: 2593467
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Serum lipids in patients with hypertension treated with prazosin].
    Bukowska H; Torbus-Lisiecka B; Pieczul-Mróz J; Gregorczyk J; Wesołowska T
    Pol Arch Med Wewn; 1986 Jul; 76(1):1-6. PubMed ID: 3808984
    [No Abstract]   [Full Text] [Related]  

  • 65. [Blood insulin and glucose in essential hypertension treated with prazosin].
    Kokot F; Sledziński Z; Mleczko Z
    Pol Arch Med Wewn; 1981 Jul; 66(1):43-50. PubMed ID: 7027200
    [No Abstract]   [Full Text] [Related]  

  • 66. Changes of hemorheological and biochemical parameters after plasma perfusion using a tryptophan-polyvinyl alcohol adsorber leading to clinical improvement in patients suffering from maculopathy.
    Widder RA; Brunner R; Engels B; Borberg H; Oette K
    Blood Purif; 1998; 16(1):15-21. PubMed ID: 9513758
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Analysis of rheologic changes in blood based on a hemorheologic profile concept].
    Murav'ev AV; Iakusevich VV; Zamyshliaev AV; Eremin NN; Murav'ev AA
    Klin Lab Diagn; 2001 Jul; (7):43-5. PubMed ID: 11530532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Refractory hypertension. Pathogenesis and therapy].
    Pape J; Brodwall E
    Tidsskr Nor Laegeforen; 1978 Apr; 98(10):497-9. PubMed ID: 675598
    [No Abstract]   [Full Text] [Related]  

  • 69. Possible mechanisms of increased blood viscosity in systemic hypertension.
    Peverill RE
    Am J Cardiol; 2000 Aug; 86(4):483. PubMed ID: 11012385
    [No Abstract]   [Full Text] [Related]  

  • 70. [Possible relationships between platelet aggregation and hematocrit values].
    Cordova C; Musca A; Perrone A; Violi F; Marigliano V
    Boll Soc Ital Biol Sper; 1978 Feb; 53(24):2473-9. PubMed ID: 637945
    [No Abstract]   [Full Text] [Related]  

  • 71. [Raised hematocrit as a risk factor of arterial hypertension].
    Kameneva MV; Timofeev VF
    Kardiologiia; 1986 Oct; 26(10):100-1. PubMed ID: 3795688
    [No Abstract]   [Full Text] [Related]  

  • 72. Spontaneous platelet aggregation in whole blood: dependence on age and haematocrit.
    Burgess-Wilson ME; Green S; Heptinstall S; Mitchell JR
    Lancet; 1984 Nov; 2(8413):1213. PubMed ID: 6150256
    [No Abstract]   [Full Text] [Related]  

  • 73. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy.
    Okrucká A; Pechán J; Mikulecký M
    Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
    Toth K; Nemes J; Czopf L; Kapronczay P; Kesmarky G; Juricskay I
    Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.
    Muravyov AV; Meiselman HJ; Yakusevich VV; Zamishlayev AV
    Clin Hemorheol Microcirc; 2002; 26(2):125-35. PubMed ID: 12082261
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Changes in platelet function in essential hypertension].
    Katori R
    Nihon Rinsho; 1992 Apr; 50 Suppl():436-43. PubMed ID: 1635226
    [No Abstract]   [Full Text] [Related]  

  • 78. [Hemorheologic changes in patients with essential hypertension treated with prazosin].
    Gerc V; Koblar V; Brkić D; Kamhi J
    Med Pregl; 1992; 45(7-8):285-7. PubMed ID: 1344459
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.